
Shuttle Pharmaceuticals Holdings, Inc. – NASDAQ:SHPH
Shuttle Pharmaceuticals Holdings stock price today
Shuttle Pharmaceuticals Holdings stock price monthly change
Shuttle Pharmaceuticals Holdings stock price quarterly change
Shuttle Pharmaceuticals Holdings stock price yearly change
Shuttle Pharmaceuticals Holdings key metrics
Market Cap | 2.25M |
Enterprise value | 6.09M |
P/E | -4.43 |
EV/Sales | N/A |
EV/EBITDA | -1.59 |
Price/Sales | N/A |
Price/Book | 1.79 |
PEG ratio | 0.01 |
EPS | -0.45 |
Revenue | N/A |
EBITDA | -5.68M |
Income | -7.34M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeShuttle Pharmaceuticals Holdings stock price history
Shuttle Pharmaceuticals Holdings stock forecast
Shuttle Pharmaceuticals Holdings financial statements
Jun 2023 | 0 | -2.18M | |
---|---|---|---|
Sep 2023 | 0 | -1.79M | |
Dec 2023 | 9.65K | -1.64M | -16989.44% |
Mar 2024 | 0 | -1.73M |
Payout ratio | 0% |
---|
2018 | |
---|---|
2020 | |
2021 | |
2022 | 0.25% |
2023 |
Jun 2023 | 8837101 | 1.90M | 21.52% |
---|---|---|---|
Sep 2023 | 7375818 | 1.76M | 23.94% |
Dec 2023 | 5951736 | 1.89M | 31.86% |
Mar 2024 | 4753921 | 1.99M | 41.91% |
Jun 2023 | -1.64M | 62.80K | -139.22K |
---|---|---|---|
Sep 2023 | -1.53M | -25.85K | 0 |
Dec 2023 | -1.06M | 87.03K | -334.44K |
Mar 2024 | -1.23M | 101.29K | -40K |
Shuttle Pharmaceuticals Holdings alternative data
Aug 2023 | 7 |
---|---|
Sep 2023 | 7 |
Oct 2023 | 7 |
Nov 2023 | 7 |
Dec 2023 | 7 |
Jan 2024 | 7 |
Feb 2024 | 7 |
Mar 2024 | 8 |
Apr 2024 | 8 |
May 2024 | 8 |
Jun 2024 | 8 |
Jul 2024 | 8 |
Shuttle Pharmaceuticals Holdings other data
Period | Buy | Sel |
---|---|---|
Dec 2023 | 0 | 7078 |
-
What's the price of Shuttle Pharmaceuticals Holdings stock today?
One share of Shuttle Pharmaceuticals Holdings stock can currently be purchased for approximately $3.17.
-
When is Shuttle Pharmaceuticals Holdings's next earnings date?
Unfortunately, Shuttle Pharmaceuticals Holdings's (SHPH) next earnings date is currently unknown.
-
Does Shuttle Pharmaceuticals Holdings pay dividends?
No, Shuttle Pharmaceuticals Holdings does not pay dividends.
-
How much money does Shuttle Pharmaceuticals Holdings make?
Shuttle Pharmaceuticals Holdings has a market capitalization of 2.25M.
-
What is Shuttle Pharmaceuticals Holdings's stock symbol?
Shuttle Pharmaceuticals Holdings, Inc. is traded on the NASDAQ under the ticker symbol "SHPH".
-
What is Shuttle Pharmaceuticals Holdings's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Shuttle Pharmaceuticals Holdings?
Shares of Shuttle Pharmaceuticals Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Shuttle Pharmaceuticals Holdings have?
As Jul 2024, Shuttle Pharmaceuticals Holdings employs 8 workers.
-
When Shuttle Pharmaceuticals Holdings went public?
Shuttle Pharmaceuticals Holdings, Inc. is publicly traded company for more then 3 years since IPO on 31 Aug 2022.
-
What is Shuttle Pharmaceuticals Holdings's official website?
The official website for Shuttle Pharmaceuticals Holdings is shuttlepharma.com.
-
Where are Shuttle Pharmaceuticals Holdings's headquarters?
Shuttle Pharmaceuticals Holdings is headquartered at One Research Court, Rockville, MD.
-
How can i contact Shuttle Pharmaceuticals Holdings?
Shuttle Pharmaceuticals Holdings's mailing address is One Research Court, Rockville, MD and company can be reached via phone at +240 4034212.
Shuttle Pharmaceuticals Holdings company profile:

Shuttle Pharmaceuticals Holdings, Inc.
shuttlepharma.comNASDAQ
8
Drug Manufacturers - Specialty & Generic
Healthcare
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
Rockville, MD 20850
CIK: 0001757499
ISIN: US8256932034
CUSIP: 825693203